Gritstone Oncology, Inc. announced that Vijay Yabannavar, Ph.D., has joined the company as executive vice president of manufacturing and technical operations. Dr. Yabannavar was most recently the vice president of global technical operations at Merck, providing technical support to drive the supply chain growth of its immune checkpoint inhibitor Keytruda (pembrolizumab).